Liver protection for kids with leukemia
Part of Blood & lymphatic, Cancer, Immune system & allergy clinical trials.
This trial tests if a medication can protect the liver during chemotherapy for children and teenagers newly diagnosed with acute lymphoblastic leukemia (ALL). It aims to reduce liver damage caused by treatment.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Age between 2 and 18 years old
- Newly diagnosed with acute lymphoblastic leukemia (ALL)
- Currently in the first phase of chemotherapy (induction phase)
- Being treated at Ain Shams University
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This early-phase study tests whether levocarnitine can reduce liver injury from a chemotherapy medicine called asparaginase in people with high-risk acute lymphoblastic leukemia (ALL). If you’re eligible, you would take levocarnitine by mouth alongside your planned standard cancer treatment to see if the liver stays healthier.
This study looks at the gut microbiome (tiny organisms in the gut) and metabolome (small chemicals in the body) in children and teens with newly diagnosed ALL. It may help researchers understand what is happening in the body early in treatment and could guide future, more personalized care.
This study looks at whether a simple blood test can help track how well treatment is working in children with leukemia. It may help doctors understand the disease better and guide future care.
This trial tests whether starting physical activity and exercise early in treatment can help children with leukemia prevent muscle loss and reduce frailty. It involves wearing a Fitbit to track activity and may help kids stay stronger during and after treatment.
This trial is for children newly diagnosed with acute lymphoblastic leukemia (ALL). It tests whether checking medicine levels in the blood can help optimize ongoing treatment (maintenance) and potentially keep the cancer under control.
This trial tests if core strengthening exercises help children with acute lymphoblastic leukemia (ALL) who are in the maintenance phase of chemotherapy. It aims to improve their physical function and quality of life.
Hear when a new Acute Lymphoblastic Leukemia trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.